Reading room

Terapia May 2023 NR 5 ( 424 )

Allergology

Editor of the issue: prof. dr hab. n. med. Piotr Kuna

Contents:

Personalization of asthma treatment in GINA 2022 Report

    Authors:
  • dr n. med. Izabela Kupryś-Lipińska
  • prof. dr hab. n. med. Piotr Kuna
Keywords: GINA 2022, SABA overuse, ICS-LABA-LAMA combination, biological therapy, anty-TSLP

What's new in GOLD 2023?

    Authors:
  • prof. nadzw. dr hab. n. med. Michał Panek
  • mgr Jacek Plichta
  • lek. Bartłomiej Olczak
  • prof. dr hab. n. med. Piotr Kuna
Keywords: chronic obstructive pulmonary disease, COPD, new guidelines GOLD 2023 Report, modified British Medical Research Council, mMRC, COPD Assessment Test, CAT, the global assessment of COPD

Diagnostics and therapy of urticaria in the light of current guidelines and Polish version of Urticaria Control Test (UCT)

    Authors:
  • dr hab. n. med. Zenon Brzoza, prof. UO
Keywords: urticaria, angioedema, diagnostics, treatment, Urticaria Control Test

Dry powder inhaler or pressurized metered dose inhaler?

    Authors:
  • prof. dr hab. n. med. Andrzej Emeryk
  • dr n. med. Kamil Janeczek
  • lek. Klaudia Panas
Keywords: dry powder inhaler, pressurized metered dose inhalers, asthma, fluticasone propionate, salmeterol

Recent advances in allergen immunotherapy

    Authors:
  • lek. Anna Mościcka
  • lek. Dominika Ochab-Krupnik
  • dr n. med. Piotr Łacwik
  • prof. dr hab. n. med. Piotr Kuna
Keywords: allergen-specific immunotherapy, SCIT, SLIT, CRD

Triple therapy in obstructive pulmonary diseases

    Authors:
  • prof. nadzw. dr hab. n. med. Michał Panek
  • lek. Bartłomiej Olczak
  • mgr Jacek Plichta
  • prof. dr hab. n. med. Piotr Kuna
Keywords: triple therapy, asthma, chronic obstructive pulmonary disease, peripheral blood eosinophils, inhaled corticosteroids, GINA and GOLD recommendations

Real educational needs in obstructive diseases – results of a nationwide observational study

    Authors:
  • dr hab. n. med. Katarzyna Górska
Keywords: asthma, inhalation errors, education, inhaler DPI, inhaler MDI, COPD, inhalation therapy

Allergic rhinitis – short review of the newest guidelines and current knowledge

    Authors:
  • lek. Magdalena Adamczewska
  • prof. dr hab. n. med. Piotr Kuna
Keywords: allergic rhinitis, ARIA, antihistamines, intranasal corticosteroids, intranasal drugs, specific immunotherapy

Bilastine – the newest antihistaminc with very high safety profile in the treatment of allergic rhinitis and conjunctivitis and urticaria

    Authors:
  • lek. Grzegorz Biliński
  • prof. dr hab. n. med. Piotr Kuna
Keywords: bilastin, safety, adverse reactions, interaction, metabolism, sedation, QT interval

Latest advancements in chronic spontaneous urticaria management

    Authors:
  • dr n. med. Marta Kołacińska-Flont
Keywords: urticaria, chronic spontaneous urticaria, omalizumab, ligelizumab, mast cell, eosinophil, barzolvolimab, lirentelimab, antihistamine drugs, MRGPRX2, type IIb autoimmunity

Mepolizumab in eosinophilic asthma and new indications: eosinophilic granulomatosis with polyangiitis (EGPA), idiopathic hypereosinophilic syndrome (HES) and chronic rhinosinusitis with nasal polyps (CRSwNP)

    Authors:
  • dr n. med. Izabela Kupryś-Lipińska
  • mgr farm. Katarzyna Molińska
  • mgr Joanna Molińska
  • prof. dr hab. n. med. Piotr Kuna
Keywords: mepolizumab, eosinophilic granulomatosis with polyangiitis, EGPA, idiopathic hypereosinophilic syndrome, HES, chronic rhinosinusitis with nasal polyps, CRSwNP

Dupilumab in bronchial asthma management

    Authors:
  • prof. dr hab. n. med. Maciej Kupczyk
Keywords: severe asthma, dupilumab, T2 inflammation, biological therapy

The use of JAK kinase inhibitors in the treatment of allergic diseases

    Authors:
  • dr n. med. Grzegorz Kardas
  • prof. dr hab. n. med. Piotr Kuna
Keywords: atopic dermatitis, asthma, JAK kinase inhibitors, upadacitinib, abrocitinib, baricitinib

Recommendations for the use of budesonide by nebulization in SARS-CoV-2 virus-infected patients with COVID-19 symptoms. Expert position

    Authors:
  • prof. dr hab. n. med. Piotr Kuna
  • prof. dr hab. n. med. Teresa Jackowska
  • dr n. med. Kamil Janeczek
  • dr hab. n. med. Katarzyna Krenke
  • prof. dr hab. n. med. Maciej Kupczyk
  • dr hab. n. med. Agnieszka Mastalerz-Migas
  • dr n. med. Izabela Kupryś-Lipińska
Keywords: COVID-19, budesonide, nebulization, prevention, respiratory system